We are dedicated to the ongoing safety surveillance and proactive risk management of all our products.
In line with our global team response, Sanofi wants to ensure patients understand the risks associated with valproate in female children, women of childbearing potential and pregnant women. Educational materials are being made available to healthcare professionals and patients to provide more information about this risk.
This applies to all brands of valproate, including Epilim, Sodium Valproate Sandoz, Valpro EC and Valproate Winthrop.
Call for reporting
Please remember that any suspected adverse events should be reported to the Therapeutic Goods Administration (TGA), or Medsafe
Company Contact
Adverse reactions can also be reported directly to Sanofi: email ae@sanofi.com or phone 02 8666 2123.
Our medical information department can be contacted for further information at medinfo.australia@sanofi.com, 1800 818 806 or 0800 283 648.
Educational Materials
You are leaving the www.sanofi.com.au website
This link will take you to a website to which our Privacy Policy does not apply. Sanofi Australia & New Zealand has no control over the contents of these sites or resources, and accepts no liability or responsibility for them or for any loss or damage that may arise from your use of them.
Do you wish to proceed?
You are leaving the www.sanofi.com.au website
You are about to visit another Sanofi website that is not governed by Australia & New Zealand regulatory.
Do you wish to proceed?
You are leaving the www.sanofi.com.au website
If you wish to access one of our Group website from another country, click Proceed.
Medical practices and regulations can be different from one country to another.
As a result, the medical information provided in the site which you are going to visit may not be appropriate for product use in your country.
You are leaving the www.sanofi.com.au website
You are leaving the www.sanofi.com.au website
You are about to visit another Sanofi website that belongs to Sanofi in Australia & New Zealand.
Do you wish to proceed?